Sorrento Therapeutics Looks Like It May Have Broken Out Of A Falling Wedge Pattern
Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares are trading higher Wednesday after the company announced it completed an acquisition of ACEA Therapeutics. The merger was completed June 1, and ACEA became a wholly owned subsidiary of Sorrento.
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously disclosed heavily pretreated advanced breast cancer patients.
Sorento Therapeutics Publishes Clinical Trial Titled ‘Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID Acute Respiratory Distress Syndrome’ To ClinicalTrials.Gov
https://clinicaltrials.gov/ct2/show/NCT04909879
Sorrento Therapeutics Publishes Clinical Trial Titled ‘Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 “Long Haul” Pulmonary Compromise’ To ClinicalTrials.Gov
https://clinicaltrials.gov/ct2/show/NCT04909892
Sorrento Therapeutics Study To Evaluate Intra-Articular Resiniferatoxin To Treat Moderate To Severe Pain From Knee Osteoarthritis Posted To Clinicaltrials Website
https://clinicaltrials.gov/ct2/show/NCT04885972